CA-VISA-INC.
17.6.2019 17:02:09 CEST | Business Wire | Press release
Visa (NYSE: V) today announced global adoption of its sensory branding suite in 25 countries via more than a dozen new partnerships. The suite is comprised of sound, animation and haptic brand cues that occur with a Visa payment transaction. In a digital world increasingly filled with voice-commands, networked appliances and unattended retail environments, Visa’s sensory branding cues offer new ways to enhance the customer experience and convey the trust and security that the Visa brand represents.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190617005240/en/
Visa was the first major payment brand to introduce multi-sensory branding , which included animation, sound and haptic vibration expressions of its brand. After an extensive creation and selection process that involved focus groups and elimination rounds, Visa landed on a single ‘energetic’ and ‘optimistic’ sound, and complementary animation and haptic vibration. Since then, Visa has forged partnerships with a range of companies around the world to deploy sensory branding, ensuring more consumers get the confidence they desire when making a payment.
With the growth of IoT and evolving consumer expectations, Visa’s sensory branding suite is strategically coming to life across the globe. A few examples include:
-
Mobile First Experiences:
- Carousell marketplace app in Singapore
- Monyx Wallet payment app from Nayax
- 11 issuer mobile wallet apps throughout the Latin America region
-
Biggest Stages in Sport:
- In-stadiums across France at the FIFA Women's World Cup™
- In-stadium at Oracle Park, home of the San Francisco Giants
-
Prominent Technology and Retail Partnerships:
- Point-of-sale (POS) terminal providers that provide technology directly to merchants, including Aurus, Equinox Payments (NA), Pax (NA and Asia), Poynt (SF), IBA (Russia), VisaNet (Uruguay)
- TSYS Genius payment processing platform
- First Data in Singapore
- Xpress-pay, a leading, flexible ePayment solution for SMBs
- Payscout, a global payment processing provider with a platform for enabling transactions in immersive environments
- Ziosk, a table service ordering and pay on-demand solution deployed in casual dining restaurants such as Olive Garden, Yard House, Chili’s, Red Robin, Outback, and TGI Friday’s
“As consumers continue to change where and how they pay in the world, the entirety of the customer experience must also evolve in ways that have trust built-in from the start,” said Lynne Biggar, chief marketing and communications officer, Visa. “Giving greater dimensionality to our brand and letting our customers see, hear or feel Visa when they pay, is an essential ingredient at a time when the physical point of sale is making way for greater digital environments. Sensory branding cues provide a way for us to express that our brand promise of speed, security, reliability and trust is still behind every transaction.”
To measure the impact of sensory branding on consumer experience, research with a sample of San Francisco Bay Area merchants1 using POYNT terminals was recently undertaken. The in-store research found that consumers who experienced sensory branding were 12% more likely to say that the merchant cares for their security. Similarly, positive perceptions of the Visa brand increased by 14% compared with those who did not experience the sensory branding at the POS, with recall of the Visa logo also increasing.
Partner Reaction & Support for Sensory Branding
“My first reaction to Visa’s sensory branding was, wow, someone finally got it,” said Osama Bedier, founder and CEO, POYNT. “These visual and audible cues will become a really important part of reinforcing the consumer experience.”
“TSYS sees the consumer payment experience evolving at the point-of-sale to be a constant interaction between the consumer and merchant. Sensory branding is a good example of how the consumer can feel their transaction was completed in a safe and secure way,” said Jim Egbert, SVP of business development and strategic partnerships, TSYS. “The consumer experience is seamless, safe and secure.”
“We are excited to be part of Visa’s innovative initiative to build trust, reinforce their brand, and improve the customer payment experience,” said Bohdan Myroniw, vice president of strategic alliances, Equinox Payments. “It’s easy, it’s understood by young and old, and it’s a fun experience.”
Onsite at Cannes
Lynne Biggar will be discussing the overall growth and efficacy of Visa’s sensory branding today at the Cannes Lions International Festival of Creativity. In a session titled “The Next Frontier of Sound and Sense Branding”, she is appearing at the Debussy Theatre, Palais I, and speaking alongside the founding partner of Listen Agency, Steve Milton. To learn more, follow @LynneBiggar on Twitter or LinkedIn .
About Visa Inc.
Visa Inc. (NYSE: V) is the world’s leader in digital payments. Our mission is to connect the world through the most innovative, reliable and secure payment network - enabling individuals, businesses and economies to thrive. Our advanced global processing network, VisaNet, provides secure and reliable payments around the world, and is capable of handling more than 65,000 transaction messages a second. The company’s relentless focus on innovation is a catalyst for the rapid growth of digital commerce on any device, for everyone, everywhere. As the world moves from analog to digital, Visa is applying our brand, products, people, network and scale to reshape the future of commerce. For more information, visit About Visa , visa.com/blog and @VisaNews .
1 Visa Internal Research, “Impact of VSB on Consumer Experience,” 2019
View source version on businesswire.com: https://www.businesswire.com/news/home/20190617005240/en/
Contact:
Visa Inc. Sheerin Salimi shesalim@visa.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
